Sales & Marketing Execution drift: Why pharmaceutical go-to-market falls short... Execution drift occurs when strategy, targeting, metrics, incentives, and behaviour gradually stop reinforcing one another.
Digital Cracking the code: How European biotechs can win in the US m... At Frontiers Health 2025, Mike Ryan, General Manager Europe at EVERSANA, tackled one of the most pressing questions for emerging pharma and biotech...
Market Access How are the US MFN and German MFG likely to impact pharmaceu... A comparison of the US MFN and German MFG.
Sales & Marketing Unlocking pharma launch potential: Integrated data strategie... Launch teams need real-time, integrated intelligence to navigate tighter markets, faster timelines, and rising expectations.
Market Access Sponsored The stealth market access strategy that’s quietly making man... There is an under-the-radar market access strategy that some manufacturers have implemented, but many others remain unaware of.
Sales & Marketing Sponsored Beyond the launch date: Why pharma must rethink readiness fo... Explore why pharma companies must rethink their NHS strategies post-launch, with tools like IQVIA'S Market Access Launch Pad.
News After setback, Rhythm gets good news on Imcivree from FDA Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.